How India landed in the rabies vaccine doghouse

Despite being the country with the most rabies-related deaths and boasting the largest rabies vaccine manufacturer, India is staring at an 80% shortfall in the supply of rabies vaccines

India has four rabies vaccine manufacturers with a combined capacity of 40-50 million doses

Despite having a big market in their home turf, makers are finding it hard to supply to the respective state governments

As a result, citizens are running from pillar to post for the life-saving vaccine

The government is planning to cap or ban exports of the vaccine

22-year-old Bale Hasda, who goes by the name Sumi, was bitten by a stray dog in Delhi’s upscale Lodhi Colony on 11 March. She wasn’t the only victim, or even the worst affected. A few others in the neighbourhood were bitten as well, with one senior citizen dying as a result of the dog attack.

Fortunately for Sumi, her employer rushed her to Delhi’s Safdarjung Hospital, one of the few public health centres in the national capital that still have stocks of the vital anti-rabies vaccine (ARV).

AUTHOR

Suraksha P

Suraksha writes on Healthcare and Pharma. She has been a journalist for five years, reporting for The New Indian Express in Bengaluru and Chennai, and The Times of India, Delhi. In her previous stints she has written on health, civic issues and education. She investigated cover up of corruption in the state health department’s think tank, narrated harrowing tales of women who underwent unwarranted hysterectomies, and wrote about how loss of biometrics came in the way of Leprosy patients getting an Aadhaar card and thereby pension. She can be reached at suraksha at the-ken dot com.

View Full Profile